RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INBX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Inhibrx Inc stock price ended at $13.56 on Tuesday, after losing 1.31%.
(Updated on Jul 02, 2024)

Sell candidate since Jun 03, 2024 Loss -24.75% PDF

The Inhibrx Inc stock price fell by -1.31% on the last day (Tuesday, 2nd Jul 2024) from $13.74 to $13.56. During the last trading day the stock fluctuated 5.25% from a day low at $13.33 to a day high of $14.03. The price has fallen in 6 of the last 10 days and is down by -4.44% for this period. Volume has increased on the last day by 44 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 171 thousand shares were bought and sold for approximately $2.31 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -56.52% during the next 3 months and, with a 90% probability hold a price between $3.23 and $8.71 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INBX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Inhibrx Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $14.39 and $22.52. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 03, 2024, and so far it has fallen -24.75%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Inhibrx Inc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.700 between high and low, or 5.25%. For the last week, the stock has had daily average volatility of 6.20%.

Inhibrx Inc is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INBX) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Inhibrx Inc to open at $13.64, and during the day (based on 14 day Average True Range), to move between $12.44 and $14.68, which gives a possible trading interval of +/-$1.12 (+/-8.24%) up or down from last closing price. If Inhibrx Inc takes out the full calculated possible swing range there will be an estimated 16.48% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $14.17, some $0.610 (4.50%) from the current price of $13.56, our system finds the risk reward not very attractive.

Is Inhibrx Inc stock A Buy?

Inhibrx Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.351 Strong Sell Candidate Unchanged

Predicted Opening Price for Inhibrx Inc of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$13.64 ( 0.590%) $13.56

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INBX

Fibonacci Support & Resistance Levels

Level Price
R3 14.34 5.75%
R2 14.07 3.78%
R1 13.91 2.56%
Price 13.56
S1 13.37 -1.38%
S2 13.21 -2.60%
S3 12.94 -4.57%

Accumulated Volume Support & Resistance Levels

Level Price
R3 16.89 24.56%
R2 15.14 11.65%
R1 14.17 4.50%
Price 13.56
S1 0 -
S2 0 -
S3 0 -

INBX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 30, 2024 May 30, 2024 Jun 20, 2024 $0.85 5.87%

FAQ

What is the symbol for Inhibrx Inc Stock and on which exchange is it traded?
The symbol for Inhibrx Inc is INBX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Inhibrx Inc Stock?
Inhibrx Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Inhibrx Inc Stock?
Inhibrx Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inhibrx Inc Stock.

What's the current price of Inhibrx Inc Stock?
As of the end of day on the Jul 02, 2024, the price of an Inhibrx Inc (INBX) share was $13.56.

What is the 52-week high and low for Inhibrx Inc Stock?
The 52-week high for Inhibrx Inc Stock is $39.79 and the 52-week low is $13.33.

What is the market capitalization of Inhibrx Inc Stock?
As of the Jul 02, 2024, the market capitalization of Inhibrx Inc is 198.899M.

When is the next earnings date for Inhibrx Inc?
The upcoming earnings date for Inhibrx Inc is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Inhibrx Inc

Inhibrx Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonis... INBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT